Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Immunocore Holdings plc (IMCR) Presents at UBS Global Biopharma Conference 2026 Transcript

17 November 2026

Amer Sports, Inc. (AS) Q3 2026 Earnings Call Transcript

17 November 2026

IBM Stock Is Hiding A Secret We’ll Learn In 2027 (And A Ticking Clock) (NYSE:IBM)

17 November 2026

Spire Inc. 2026 Q4 – Results – Earnings Call Presentation (NYSE:SR) 2026-11-17

17 November 2026

Fidelity Limited Term Bond Fund Q3 2026 Commentary

17 November 2026
Facebook X (Twitter) Instagram
Business Tuesday, Nov 17
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Immunocore Holdings plc (IMCR) Presents at UBS Global Biopharma Conference 2026 Transcript
News

Immunocore Holdings plc (IMCR) Presents at UBS Global Biopharma Conference 2026 Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk17 November 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

Immunocore Holdings plc (IMCR) UBS Global Biopharma Conference 2026 November 17, 2026 10:20 AM EST

Company Participants

Travis Coy – CFO, Executive VP & Head of Corporate Development

Conference Call Participants

Dina Elmonshed – UBS Investment Bank, Research Division

Presentation

Dina Elmonshed
UBS Investment Bank, Research Division

Hello, everyone. My name is Dina Elmonshed, one of the biotech analysts here at UBS, and I am excited and pleased to welcome Travis Coy, Chief Financial Officer of Immunocore. I am excited for us to get started on this.

Question-and-Answer Session

Dina Elmonshed
UBS Investment Bank, Research Division

And so maybe we can start with a couple of questions around the commercial business for KIMMTRAK.

Maybe just we are probably in our fourth year of launch now. And so given pretty peak penetration levels in especially OUS market and maybe 70% in the U.S. nearly there. So maybe just thinking about where are the remaining growth drivers, particularly in the community setting, both in the U.S. and OUS? And where do you see KIMMTRAK from here in the outer years?

Travis Coy
CFO, Executive VP & Head of Corporate Development

Yes. No, thanks, Dave. First of all, thank you for having me. Thank you for having us. So all good question on KIMMTRAK. We’re really pleased that KIMMTRAK has become the standard of care across all major markets. And you’re elaborating to some of the penetration levels we had. We’re at 70% plus penetration across all markets. And so as we look at the growth, naturally in this part of the product’s life cycle, we’re seeing growth begin to moderate. It’s a good thing, right? We did a good job on launch, right?

Dina Elmonshed
UBS Investment Bank, Research Division

Launched very quickly.

Travis Coy
CFO, Executive VP & Head of Corporate Development

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Amer Sports, Inc. (AS) Q3 2026 Earnings Call Transcript

IBM Stock Is Hiding A Secret We’ll Learn In 2027 (And A Ticking Clock) (NYSE:IBM)

Spire Inc. 2026 Q4 – Results – Earnings Call Presentation (NYSE:SR) 2026-11-17

Fidelity Limited Term Bond Fund Q3 2026 Commentary

Stryker Corporation (SYK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

The Bank Of Nvidia Is Closed: Now What? (NASDAQ:SOXX)

Gladstone Land: Q3 Growth Spurt, Caution Remains Over Farmland Earnings Volatility (LAND)

Paladin Energy Ltd (PALAF) Shareholder/Analyst Call Transcript

Nextpower Inc. (NXT) Analyst/Investor Day Transcript

Editors Picks

Amer Sports, Inc. (AS) Q3 2026 Earnings Call Transcript

17 November 2026

IBM Stock Is Hiding A Secret We’ll Learn In 2027 (And A Ticking Clock) (NYSE:IBM)

17 November 2026

Spire Inc. 2026 Q4 – Results – Earnings Call Presentation (NYSE:SR) 2026-11-17

17 November 2026

Fidelity Limited Term Bond Fund Q3 2026 Commentary

17 November 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Stryker Corporation (SYK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

17 November 2026

The Bank Of Nvidia Is Closed: Now What? (NASDAQ:SOXX)

17 November 2026

Gladstone Land: Q3 Growth Spurt, Caution Remains Over Farmland Earnings Volatility (LAND)

17 November 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.